Join
Live feed
·
INSIDERFilingvia Quantisnow
Fulcrum Therapeutics Inc. logo

SEC Form 4: Gould Robert J sold $101,490 worth of shares (6,766 units at $15.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 499,864 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FULC (Fulcrum Therapeutics Inc.) and more on Quantisnow.